Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Studying lactate levels in patients with septic shock

Official title: Lactate Kinetics in Patients Treated for Septic Shock

Run by Karolinska University Hospital · NCT05349370 · Data updated 2026-11-12

This study is testing how lactate levels change in adults with septic shock in the ICU to see if it can help us understand their condition better and improve their care.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment60 (estimated)
SponsorKarolinska University Hospital
Academic / other
Locations1 site (Stockholm, Stockholm County)
StatusRecruiting
StartedDecember 28, 2022
Main results expectedMarch 30, 2026
Study endsDecember 31, 2026
Registry record updatedMay 23, 2025
Trial IDNCT05349370 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 17 years old who have been diagnosed with sepsis and have an arterial catheter in place.

Probably not a fit

Patients with mitochondrial defects, degenerative muscle diseases, or terminal liver failure may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates lactate kinetics in adult patients diagnosed with septic shock who are admitted to the Intensive Care Unit. Participants will receive a bolus injection of stable isotopically labeled lactate, followed by multiple blood samples taken over a two-hour period to analyze lactate production and consumption. The goal is to better understand the metabolic processes involved in sepsis and how lactate levels correlate with patient outcomes. The study aims to recruit patients within 72 hours of symptom onset to ensure timely data collection.

Why it matters

Potential benefit: If successful, this research could lead to improved management and treatment strategies for patients suffering from septic shock.

How similar studies have gone: While studies on lactate kinetics exist, this specific approach using isotopically labeled lactate in septic patients is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Sepsis
* Age \>17 years
* Arterial catheter
* Lactate \> 2 mmol at any time point prior to inclusion

Exclusion Criteria:

* Mitochondrial defect
* Degenerative muscle disease
* Terminal liver failure

Where it's running

  • Karolinska University Hospital
    Stockholm, Stockholm County, Sweden
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.